Learn More
Selleck Chemical LLC Tremelimumab-A2021-1MG

Supplier: Selleck Chemical LLC A20211MG
Tremelimumab (Ticilimumab CP-675 206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.